Stock Screener App

Frei -

Installieren

2.12

6.00% 0.12

after-market

Handel nachbörslich: 2.12

Allogene Therapeutics Inc (ALLO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	44.90	-	65.19	60.49	71.77
Operating Income/Loss	-44.90	-	-65.19	-60.49	-71.77
Nonoperating Income/Loss	3.501	-	5.458	0.994	5.481
Income/Loss From Continuing Operations Before Tax	18.73% -41.40	-50.94	-59.73	-59.50	-66.29
Income/Loss From Continuing Operations After Tax	18.73% -41.40	-50.94	-59.73	-59.94	-66.29
Net Income/Loss	18.73% -41.40	-50.94	-59.73	-59.94	-66.29
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	222.04	-	215.36	5.2919	209.19
Diluted Average Shares	222.04	-	215.36	5.2919	209.19
Basic Earnings Per Share	-0.19	-	-0.28	-0.28	-0.32
Diluted Earnings Per Share	-0.19	-	-0.28	-0.28	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$29.66

0.98%

BNTX

$92.25

0.12%

INSM

$108.87

2.48%

RPRX

$53.86

1.17%

ONC

$302.44

2.52%

RVMD

$154.89

2.20%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters